France Archives

News and Trends 31 Jul 2019

French Biotech’s Insulin Resistance Treatment Boosted by €67M Series A

The French company Alizé Pharma III has raised a Series A round of €67M to push two peptide drugs into phase I, including a drug treating rare genetic conditions causing insulin resistance. The money will advance Alizé Pharma III’s two preclinical drugs into clinical trials, with phase I trials expected to begin in 2020. One […]

July 31, 2019 - 2 minutesmins - By Jonathan Smith

microphyt microalgae obesity cognitive decline

More News! 11 Jul 2019

French Company Raises €29M to Sell Supplements and Cosmetics from Microalgae

The French biotech Microphyt has raised €28.5M ($32M) to commercialize nutritional and cosmetic products harvested from microalgae. Over the next 18 months, Microphyt will use the money to ramp up its workforce and industrial capacity in preparation for pushing its microalgal food ingredients and cosmetics to market. The company is developing technology to overcome a […]

July 11, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 10 Jul 2019

French Startup’s Universal Flu Vaccine Development Boosted by €8M Series A

The French biotech Osivax has advanced in the race to develop a universal flu vaccine, raising €8M to achieve clinical proof-of-concept. Osivax will use most of the funding to progress its lead candidate vaccine towards market approval. Targeting all strains of influenza A viruses, the vaccine is currently in a phase I trial, with results […]

July 10, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 10 Jul 2019

The Top 10 Biotechs You’ll Find in Lyon

Lyon is one of the hotspots for biotech in Europe. Here are 10 of the most successful biotech companies in this beautiful French city. The second largest city in France (after Paris), Lyon boasts a thriving biotech ecosystem. In addition to the young startups and large biotech companies in the city, Lyon is also the […]

July 10, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 Jul 2019

French Biotech’s Plant Extract Cuts Blood Glucose in Prediabetic People

A plant extract developed by the French biotech Valbiotis is the first food supplement to reduce blood glucose levels in people at high risk of developing type 2 diabetes. In a phase IIa trial, Valbiotis compared its food supplement with a placebo in 51 people with prediabetes. After six months, the supplement had reduced blood […]

July 5, 2019 - 2 minutesmins - By Jonathan Smith

melanoma yukin therapeutics antibody cancer nice

Startup Scout 5 Jul 2019

This Biotech Helps the Immune System to Infiltrate and Destroy Tumors

The Nice-based biotech company Yukin Therapeutics is developing drugs that can work together with checkpoint inhibitors to help the immune system smash tumors such as melanoma. Mission: To develop a drug that can change the tumor microenvironment to allow the immune system to infiltrate and destroy the tumor more effectively. This could give a big […]

July 5, 2019 - 3 minutesmins - By Jonathan Smith

nash liver fibrosis genfit terns pharmaceuticals organ

News and Trends 25 Jun 2019

Genfit’s NASH Drug to Be Developed in China in Deal Worth up to €200M

The US-Chinese company Terns Pharmaceuticals will develop and commercialize Genfit’s phase III drug elafibranor for the chronic liver disease NASH in China. As part of the deal, Genfit will receive a €31M ($35M) upfront fee and up to €170M ($193M) in developmental milestone payments. The two companies will also collaborate on other development programs for […]

June 25, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Jun 2019

French Biotech Raises €20M to Prevent Hearing Loss

The hearing loss biotech Sensorion has issued bonds to raise €20M, which it will use to fund the phase II development for first-in-class drugs treating hearing loss and severe vertigo. The money will pay for phase II trials of Sensorion’s two most advanced treatments, which are small molecule drugs to treat sudden deafness and acute […]

June 14, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 13 Jun 2019

French Startup to Produce Sustainable Textile Dyes Using Microbes

Paris-based PILI has raised €3.6M that will take its technology to produce dyes through microbial fermentation to an industrial scale. Founded in 2015, PILI seeks to disrupt the unsustainable production of dyes. Just in the textile industry, dyes are a €8B market. However, the production of these chemicals relies on petrochemical processes that require toxic […]

June 13, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

gensight gene therapy lhon genetic blindness

News and Trends 29 May 2019

After Unexpected Setback, GenSight Seeks Approval for Blindness Gene Therapy

The French biotech GenSight will apply for regulatory approval for its gene therapy despite the treatment unexpectedly resulting in the improvement of the eyes treated with a placebo in a phase III trial. GenSight is developing a gene therapy designed to treat progressive vision loss caused by the rare genetic condition Leber hereditary optic neuropathy. […]

May 29, 2019 - 2 minutesmins - By Jonathan Smith

treefrog therapeutics cell therapy parkinsons disease

News and Trends 13 May 2019

Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks

The French company Treefrog Therapeutics has raised over €7M in Series A investment to develop its encapsulation technology to improve the production of stem cells for cell therapies. Part of the Series A money will help Treefrog to automate its stem cell production process by 2021. The round will also fund the development of a […]

May 13, 2019 - 3 minutesmins - By Jonathan Smith

liver fibrosis alentis switzerland cirrhosis cancer

News and Trends 30 Apr 2019

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Founded in March this year, Alentis Therapeutics has bagged a Series A round of €11.1M (CHF 12.5M) to develop antibody drugs treating liver fibrosis, which currently has no approved treatments. Liver fibrosis is the scarring of liver tissue, which can happen as a consequence of aging, chronic hepatitis or conditions such as non-alcoholic steatohepatitis (NASH). […]

April 30, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

French Biotech’s Insulin Resistance Treatment Boosted by €67M Series A

French Company Raises €29M to Sell Supplements and Cosmetics from Microalgae

French Startup’s Universal Flu Vaccine Development Boosted by €8M Series A

The Top 10 Biotechs You’ll Find in Lyon

French Biotech’s Plant Extract Cuts Blood Glucose in Prediabetic People

This Biotech Helps the Immune System to Infiltrate and Destroy Tumors

Genfit’s NASH Drug to Be Developed in China in Deal Worth up to €200M

French Biotech Raises €20M to Prevent Hearing Loss

French Startup to Produce Sustainable Textile Dyes Using Microbes

After Unexpected Setback, GenSight Seeks Approval for Blindness Gene Therapy

Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!